Factors That Influence the Approach to Screening for Hepatitis C Risk Factors (N = 494*)
| Yes (% [n]) | No (% [n]) | Not Applicable (% [n]) | |
|---|---|---|---|
| Consequences of untreated hepatitis C can be serious for most people | 89.5 (437) | 7.0 (34) | 3.5 (17) |
| Guideline recommendations | 75.0 (366) | 25.0 (122) | — |
| Presence of comorbidities in patient | 73.5 (358) | 26.5 (129) | — |
| Treatment availability | 54.8 (268) | 45.2 (221) | — |
| Treatment effectiveness (ability to improve outcome) | 50.0 (243) | 38.1 (185) | 11.9 (58) |
| Other competing issues | 44.5 (216) | 55.5 (269) | — |
| High prevalence of hepatitis C among my patients | 44.5 (217) | 25.0 (122) | 30.5 (149) |
| Treatment intolerance | 44.4 (216) | 55.6 (270) | — |
| Financial barriers | 39.3 (190) | 60.7 (294) |
* Minor differences in item responses (range, 484–9).